Skip to content

Clinical trials

Phase 3 Blast Crisis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Blast Crisis Phase: Phase 3 Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20011
20022
20041
20051
20061
20071
20085
20091

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed20
Terminated2
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fred Hutchinson Cancer Center3
Memorial Sloan Kettering Cancer Center3
Alliance for Clinical Trials in Oncology2
European Organisation for Research and Treatment of Cancer - EORTC2
Jonsson Comprehensive Cancer Center2
Vanderbilt-Ingram Cancer Center2
Case Comprehensive Cancer Center1
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium1
INSYS Therapeutics Inc1
Martin, Paul1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Blast Crisis24
Precursor Cell Lymphoblastic Leukemia-Lymphoma24
Burkitt Lymphoma23
Leukemia, Myeloid, Accelerated Phase23
Leukemia, Myeloid, Chronic-Phase23
Leukemia, Lymphocytic, Chronic, B-Cell22
Lymphoma, B-Cell, Marginal Zone22
Lymphoma, Follicular22
Lymphoma, Large B-Cell, Diffuse22
Lymphoma, Large-Cell, Immunoblastic22

Trials

Showing 26 to 24 of 24. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.